Integrated Imaging for Ovarian Cancer-Recording

Video Transcription

Video Summary

The IGCS–Society of Abdominal Radiology session focused on integrating imaging with clinical decision-making in ovarian cancer.<br /><br />For adnexal lesions, speakers highlighted O-RADS ultrasound and MRI as standardized tools for estimating malignancy risk and guiding follow-up, further imaging, or referral to gynecologic oncology. Physiologic findings and classic benign lesions can often be recognized confidently, while indeterminate O-RADS 3 lesions remain a clinical challenge. Ultrasound is the primary assessment; MRI can clarify whether suspected solid components are enhancing tumor or benign debris and can improve specificity.<br /><br />In advanced ovarian cancer, imaging helps assess disease distribution, surgical resectability, and operative complexity. CT is the main staging modality, with MRI and PET-CT used selectively for problem-solving or suspected recurrence. Reports should systematically describe sites that may affect surgery, including mesenteric and small-bowel involvement, upper-abdominal disease, pelvic organ interfaces, and distant metastases. However, imaging can underestimate small or diffuse peritoneal and bowel-serosal disease, so findings must be interpreted with these limitations in mind.<br /><br />The speakers emphasized actionable, structured reporting and close collaboration between radiologists and gynecologic oncologists. A shared understanding of treatment pathways and imaging limits can improve triage, avoid unnecessary procedures, and support appropriate surgical planning.

Keywords

ovarian cancer

adnexal lesions

O-RADS ultrasound

O-RADS MRI

malignancy risk

gynecologic oncology

advanced ovarian cancer

CT staging

PET-CT

surgical resectability

structured reporting

peritoneal disease

imaging triage